✦ LIBER ✦

Treatment of bipolar affective illness with zimeldine, a 5-HT uptake inhibitor

✍ Scribed by A. Coppen; M.T. Abou-Saleh; K.M. Wood; M.J. Mitchell

Book ID: 118388359
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 166 KB
Volume: 7
Category: Article
ISSN: 0165-0327
DOI: 10.1016/0165-0327(84)90055-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Citalopram: A new potent inhibitor of se

Citalopram: A new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties

✍ Leszek Pawłowski; Joanna Ruczynska; Zbigniew Górka 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 485 KB

Citalopram (1--16 mg/kg), but not amitriptyline, clomipramine, imipramine or zimelidine, stimulated the hind limb flexor reflex in the spinal rat. This stimulatory effect was abolished by serotonin (5-HT) receptor blocking agents (cyproheptadine, metergoline) and prevented ty p-chlorophenylalanine,

Effects of zimeldine, a selective 5-HT r

Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats

✍ Bjørn Bjorvatn; Reidun Ursin 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 633 KB

Femoxetine - a new 5-HT uptake inhibitor

Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine

✍ P. J. Kangasniemi; T. Nyrke; A. H. Lang; E. Petersen 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

Vilazodone: A 5-HT1A Receptor Agonist/Se

Vilazodone: A 5-HT1A Receptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders

✍ Lee A. Dawson; Jeannette M. Watson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

Drug plasma levels and platelet 5-HT upt

Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.

✍ K Wood; C Swade; M Abou-Saleh; P Milln; A Coppen 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

Early experience with CGP 4718 A (Serclo

Early experience with CGP 4718 A (Sercloremine), a new selective and reversible MAO-A and 5-HT-uptake inhibitor, in the treatment of depressive patients

✍ A. Delini-Stula; R. Fischbach; F. Gnirss; E. Bures; W. Pöldinger 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB